daunorubicin liposomal 44 MG

RxNorm concept 1942739, clinical drug component (scdc).

RxCUI: 1942739
Term type: Clinical drug component (SCDC)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1942739 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

daunorubicin 3109

Other names

DAUNOrubicin liposomal 44 MG

Related concepts

cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection (SCD, constitutes)
cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] (SBD, constitutes)
daunorubicin (IN, has ingredient)
daunorubicin liposomal (PIN, has precise ingredient)
cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] (SBDC, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 1942739 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1942739 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1942739. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.